- Home
- NVST vs SLNO Comparison
NVST vs SLNO Comparison
Compare NVST & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVST
- SLNO
- Stock Information
- Founded
- NVST 2018
- SLNO 1999
- Country
- NVST United States
- SLNO United States
- Employees
- NVST N/A
- SLNO N/A
- Industry
- NVST Medical/Dental Instruments
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- NVST Health Care
- SLNO Health Care
- Exchange
- NVST Nasdaq
- SLNO Nasdaq
- Market Cap
- NVST 3.3B
- SLNO 3.2B
- IPO Year
- NVST 2019
- SLNO 2014
- Fundamental
- Price
- NVST $17.59
- SLNO $76.78
- Analyst Decision
- NVST Hold
- SLNO Strong Buy
- Analyst Count
- NVST 12
- SLNO 9
- Target Price
- NVST $20.45
- SLNO $103.33
- AVG Volume (30 Days)
- NVST 2.6M
- SLNO 955.8K
- Earning Date
- NVST 05-01-2025
- SLNO 05-07-2025
- Dividend Yield
- NVST N/A
- SLNO N/A
- EPS Growth
- NVST N/A
- SLNO N/A
- EPS
- NVST N/A
- SLNO N/A
- Revenue
- NVST $2,503,900,000.00
- SLNO N/A
- Revenue This Year
- NVST $2.29
- SLNO N/A
- Revenue Next Year
- NVST $3.15
- SLNO N/A
- P/E Ratio
- NVST N/A
- SLNO N/A
- Revenue Growth
- NVST N/A
- SLNO N/A
- 52 Week Low
- NVST $14.22
- SLNO $36.93
- 52 Week High
- NVST $23.00
- SLNO $80.91
- Technical
- Relative Strength Index (RSI)
- NVST 60.32
- SLNO 65.28
- Support Level
- NVST $16.29
- SLNO $72.23
- Resistance Level
- NVST $18.07
- SLNO $80.99
- Average True Range (ATR)
- NVST 0.68
- SLNO 3.06
- MACD
- NVST 0.28
- SLNO -0.37
- Stochastic Oscillator
- NVST 85.09
- SLNO 64.59
About NVST Envista Holdings Corporation
Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments comprising Specialty Products and Technologies and Equipment and Consumables. The Company's Specialty Products & Technologies segment develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. The Company's Equipment & Consumables segment manufactures dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.